Back to search results

OMT for Respiratory Illness in Older Adults

This study is looking at how Osteopathic Manipulative Therapy (OMT) can help newly diagnosed patients with respiratory illnesses like pneumonia, sinusitis, or bronchitis. OMT involves manual pressure and physical stimulation to encourage fluid movement and immune response. Researchers believe that adding OMT to standard care (like medication) could help lessen your symptoms faster and shorten how long you are sick. You may be able to join if you are 65 to 100 years old, have a new diagnosis of an upper respiratory illness, sinusitis, bronchitis, or pneumonia, and are being seen at Geisinger 65-Forward Buckhorn, PA clinic. The study aims to see how much OMT improves symptom severity and overall sickness duration.

Study design
This interventional study plans to enroll 68 participants. The phase of the study is not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your symptoms and sickness duration will be measured throughout the study, which can last up to one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06495021

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

Recruiting
NAAges 65+InterventionalTreatment
Geisinger Clinic
~68 participants
Updated 2026-08-11 on ClinicalTrials.gov
What's tested:Lymphatic Pump Osteopathic Manipulative Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment.
Measured over Through study completion of up to one year.

Conditions

Pneumonia
Sinusitis
Bronchitis
Respiratory Disease
Respiratory Tract Infections

Explore related trials

BronchitisPneumoniaRespiratory tract infectionSinusitis

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Margaret Moore, DO · PRINCIPAL_INVESTIGATOR · Physician

Who to contact

Margaret Moore, DO
[email protected]
(570) 416-5435
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care.
Patients age of 65-100
New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit.

Exclusion

Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities.
Patients actively receiving any type of cancer treatment
Patients with active or previously diagnosed liver disease.

What this trial measures

  • To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment.Through study completion of up to one year.

    Survey given to patients will provide feedback to capture their symptom severity at the time of diagnosis and 5 days post-diagnosis